Hypromellose Eye recalls
The FDA has published 1 recall involving Hypromellose Eye since 2026. The latest was reported on 7 Oct 2026. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 7 Oct 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why hypromellose eye is recalled
Companies
By year
Ongoing hypromellose eye recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Focus PI Hypromellose 0.7% Formula, 0.3 FL O per vial, Sterile recalledFocus Pi | Aurolab Trust | Sterility | VA |
All hypromellose eye recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Focus PI Hypromellose 0.7% Formula, 0.3 FL O per vial, Sterile recalledFocus Pi | Aurolab Trust | Sterility | VA |
Should you stop taking Hypromellose Eye?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.